Supplier News—The Preval Group recently introduced two new products for the retail channel—Wrecking Balm tattoo-fade system and Quietus, a homeopathic remedy for symptoms of tinnitus.
With Wrecking Balm, available as a direct-to-consumer brand since 2006, and more recently through tattoo parlors, there is the potential for a new category in the drug channel. The product contains DemoMatic, approved as a Class I device by the Food and Drug Administration and a Suffusion gel that helps exfoliate the upper layers of the skin, among other ingredients. Current retail packaging contains between a one- to two-month supply of the product, but it takes, on average, between six and eight months to fully fade the tattoo, which means return business.
Quietus offers symptomatic relief to the symptoms of tinnitus, a ringing in the ears associated with exposure to loud noise that about 1-in-6 Americans experience in their lifetime.
Retailer News—Drugstore.com earlier this month announced the “grand opening” of its latest destination URL—SexualWellBeing.com, a new online retail boutique with thousands of products for sexual health.
“Our goal is to provide the best value, selection and customer experience for people shopping for sexual health products online,” stated David Lonczak, drugstore.com VP and chief marketing officer. “Initial response from customers has been positive as we are able to offer a broader selection of products on SexualWellBeing.com than on drugstore.com.” Customers also will find items for personal care, grooming, family planning, flowers and gifts on SexualWellBeing.com.
Hy-Vee celebrates the other white meat
WEST DES MOINES, Iowa A lot of people complain about pork barrel spending, but not Midwest supermarket chain Hy-Vee.
October is National Pork Month, and the West Des Moines, Iowa-based Hy-Vee announced Friday that sales of the meat have increased more than 25% over October 2008. The chain said it was on track to increase pork tonnage by more than 30%.
“With pork prices the lowest they’ve been in more than a decade, we’ve focused our marketing efforts on promoting pork as a great value for consumers,” Hy-Vee assistant VP meat operations Kenan Judge said in a statement. “Today’s shopper is looking for nutritious, economical meal ideas, and pork perfectly fits the bill.”
Patients prefer new diabetes drug Victoza over its competitor, survey finds
MONTREAL A new diabetes drug satisfied patients more than its competitor, according to a study funded by the drug’s manufacturer.
According to data on 379 patients who took the Diabetes Treatment Satisfaction Questionnaires, presented Thursday at the 20th World Diabetes Congress and published in medical journal The Lancet, patients taking Novo Nordisk’s drug Victoza (liraglutide) perceived less abnormally low or high blood sugar levels — known respectively as hypoglycemia and hyperglycemia — than those taking Byetta (exenatide), made by Eli Lilly & Co., Amylin Corp. and Alkermes.
Victoza is approved in Europe, but Novo Nordisk is still waiting for approval from the Food and Drug Administration in the United States.
“Liraglutide has shown here in a convincing study that it is associated with less nausea, less perceived hypoglycemia and definitely higher patient satisfaction compared to exenatide,” principal investigator Wolfgang Schmidt said in a statement. “Patient-reported outcomes data is an important extension of the efficacy data. If a patient is satisfied with his or her treatment, then they are much more likely to really stick to the treatment over the long term, which is necessary in Type 2 diabetes.”